153 related articles for article (PubMed ID: 26407907)
21. Expression, promoter usage and parental imprinting status of insulin-like growth factor II (IGF2) in human hepatoblastoma: uncoupling of IGF2 and H19 imprinting.
Li X; Adam G; Cui H; Sandstedt B; Ohlsson R; Ekström TJ
Oncogene; 1995 Jul; 11(2):221-9. PubMed ID: 7624139
[TBL] [Abstract][Full Text] [Related]
22. Loss of imprinting in colorectal cancer linked to hypomethylation of H19 and IGF2.
Cui H; Onyango P; Brandenburg S; Wu Y; Hsieh CL; Feinberg AP
Cancer Res; 2002 Nov; 62(22):6442-6. PubMed ID: 12438232
[TBL] [Abstract][Full Text] [Related]
23. Insulin-like growth factor 2 expression in prostate cancer is regulated by promoter-specific methylation.
Küffer S; Gutting T; Belharazem D; Sauer C; Michel MS; Marx A; Trojan L; Ströbel P
Mol Oncol; 2018 Feb; 12(2):256-266. PubMed ID: 29239100
[TBL] [Abstract][Full Text] [Related]
24. The JAZF1-SUZ12 fusion protein disrupts PRC2 complexes and impairs chromatin repression during human endometrial stromal tumorogenesis.
Ma X; Wang J; Wang J; Ma CX; Gao X; Patriub V; Sklar JL
Oncotarget; 2017 Jan; 8(3):4062-4078. PubMed ID: 27845897
[TBL] [Abstract][Full Text] [Related]
25. Essential Role of DNA Methyltransferase 1-mediated Transcription of Insulin-like Growth Factor 2 in Resistance to Histone Deacetylase Inhibitors.
Min HY; Lee SC; Woo JK; Jung HJ; Park KH; Jeong HM; Hyun SY; Cho J; Lee W; Park JE; Kwon SJ; Lee HJ; Ni X; Shin YK; Johnson FM; Duvic M; Lee HY
Clin Cancer Res; 2017 Mar; 23(5):1299-1311. PubMed ID: 27582487
[No Abstract] [Full Text] [Related]
26. A methyl-deficient diet modifies histone methylation and alters Igf2 and H19 repression in the prostate.
Dobosy JR; Fu VX; Desotelle JA; Srinivasan R; Kenowski ML; Almassi N; Weindruch R; Svaren J; Jarrard DF
Prostate; 2008 Aug; 68(11):1187-95. PubMed ID: 18459101
[TBL] [Abstract][Full Text] [Related]
27. Frequent IGF2/H19 domain epigenetic alterations and elevated IGF2 expression in epithelial ovarian cancer.
Murphy SK; Huang Z; Wen Y; Spillman MA; Whitaker RS; Simel LR; Nichols TD; Marks JR; Berchuck A
Mol Cancer Res; 2006 Apr; 4(4):283-92. PubMed ID: 16603642
[TBL] [Abstract][Full Text] [Related]
28. Alterations in expression of imprinted genes from the H19/IGF2 loci in a multigenerational model of intrauterine growth restriction (IUGR).
Gonzalez-Rodriguez P; Cantu J; O'Neil D; Seferovic MD; Goodspeed DM; Suter MA; Aagaard KM
Am J Obstet Gynecol; 2016 May; 214(5):625.e1-625.e11. PubMed ID: 26880735
[TBL] [Abstract][Full Text] [Related]
29. Targeted tumor gene therapy based on loss of IGF2 imprinting.
Pan Y; He B; Li T; Zhu C; Zhang L; Wang B; Xu Y; Qu L; Hoffman AR; Wang S; Hu J
Cancer Biol Ther; 2010 Aug; 10(3):290-8. PubMed ID: 20592487
[TBL] [Abstract][Full Text] [Related]
30. Switch from monoallelic to biallelic human IGF2 promoter methylation during aging and carcinogenesis.
Issa JP; Vertino PM; Boehm CD; Newsham IF; Baylin SB
Proc Natl Acad Sci U S A; 1996 Oct; 93(21):11757-62. PubMed ID: 8876210
[TBL] [Abstract][Full Text] [Related]
31. DNA methylation reactivates GAD1 expression in cancer by preventing CTCF-mediated polycomb repressive complex 2 recruitment.
Yan H; Tang G; Wang H; Hao L; He T; Sun X; Ting AH; Deng A; Sun S
Oncogene; 2016 Jul; 35(30):3995-4008. PubMed ID: 26549033
[TBL] [Abstract][Full Text] [Related]
32. Parental imprinting: potentially active chromatin of the repressed maternal allele of the mouse insulin-like growth factor II (Igf2) gene.
Sasaki H; Jones PA; Chaillet JR; Ferguson-Smith AC; Barton SC; Reik W; Surani MA
Genes Dev; 1992 Oct; 6(10):1843-56. PubMed ID: 1383088
[TBL] [Abstract][Full Text] [Related]
33. A novel pathway links oxidative stress to loss of insulin growth factor-2 (IGF2) imprinting through NF-κB activation.
Yang B; Wagner J; Damaschke N; Yao T; Wuerzberger-Davis SM; Lee MH; Svaren J; Miyamoto S; Jarrard DF
PLoS One; 2014; 9(2):e88052. PubMed ID: 24558376
[TBL] [Abstract][Full Text] [Related]
34. Loss of genomic imprinting of insulin-like growth factor 2 is strongly associated with cellular proliferation in normal hematopoietic cells.
Hofmann WK; Takeuchi S; Frantzen MA; Hoelzer D; Koeffler HP
Exp Hematol; 2002 Apr; 30(4):318-23. PubMed ID: 11937266
[TBL] [Abstract][Full Text] [Related]
35. Association of chromosome arm 16q loss with loss of imprinting of insulin-like growth factor-II in Wilms tumor.
Mummert SK; Lobanenkov VA; Feinberg AP
Genes Chromosomes Cancer; 2005 Jun; 43(2):155-61. PubMed ID: 15761865
[TBL] [Abstract][Full Text] [Related]
36. Loss of imprinting of insulin growth factor II gene: a potential heritable biomarker for colon neoplasia predisposition.
Cruz-Correa M; Cui H; Giardiello FM; Powe NR; Hylind L; Robinson A; Hutcheon DF; Kafonek DR; Brandenburg S; Wu Y; He X; Feinberg AP
Gastroenterology; 2004 Apr; 126(4):964-70. PubMed ID: 15057734
[TBL] [Abstract][Full Text] [Related]
37. Loss of imprinting of insulin-like growth factor-II (IGF2) gene in distinguishing specific biologic subtypes of Wilms tumor.
Ravenel JD; Broman KW; Perlman EJ; Niemitz EL; Jayawardena TM; Bell DW; Haber DA; Uejima H; Feinberg AP
J Natl Cancer Inst; 2001 Nov; 93(22):1698-703. PubMed ID: 11717330
[TBL] [Abstract][Full Text] [Related]
38. [Effect of recombinant adenovirus Ad-DT-A in targeted therapy for malignant cancer cell lines with loss of IGF2 imprinting].
Pan YQ; He BS; Zhu C; Qu LL; Xu XF; Wang SK
Zhonghua Zhong Liu Za Zhi; 2011 Nov; 33(11):816-21. PubMed ID: 22335945
[TBL] [Abstract][Full Text] [Related]
39. The E2F6 Transcription Factor is Associated with the Mammalian SUZ12-Containing Polycomb Complex.
Shirahama Y; Yamamoto K
Kurume Med J; 2023 Feb; 67(4):171-183. PubMed ID: 36464274
[TBL] [Abstract][Full Text] [Related]
40. Temporal stability and age-related prevalence of loss of imprinting of the insulin-like growth factor-2 gene.
Cruz-Correa M; Zhao R; Oviedo M; Bernabe RD; Lacourt M; Cardona A; Lopez-Enriquez R; Wexner S; Cuffari C; Hylind L; Platz E; Cui H; Feinberg AP; Giardiello FM
Epigenetics; 2009 Feb; 4(2):114-8. PubMed ID: 19242102
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
